These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 6817723

  • 1. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
    [Abstract] [Full Text] [Related]

  • 2. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Pharmacology; 1982 Sep; 24(3):193-200. PubMed ID: 6803262
    [Abstract] [Full Text] [Related]

  • 3. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
    Gervasi GB, Bartoli C, Catalani R, Farina C, Carpita G, Caccia G, Ammannati P.
    Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altering the course of cataracts in diabetic rats.
    Fukushi S, Merola LO, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J, Kim CS, Sohn E, Lee YM, Kim JS.
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S, Kikuchi C, Ono T, Notsu Y.
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G, Leuenberger PM.
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 18. Regulation of lens aldose reductase activity by nitric oxide.
    Srivastava S, Tammali R, Chandra D, Greer DA, Ramana KV, Bhatnagar A, Srivastava SK.
    Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase in early streptozotocin-induced diabetic rat lens.
    Garadi R, Lou MF.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
    [Abstract] [Full Text] [Related]

  • 20. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A, Kelly K, Cruz E.
    Pharmacology; 1985 Nov; 31(3):170-9. PubMed ID: 3931105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.